-
1
-
-
0033519010
-
Under-reporting of antibiotic anaphylaxis may put patients at risk
-
Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999;353:1157-8.
-
(1999)
Lancet
, vol.353
, pp. 1157-1158
-
-
Pumphrey, R.S.1
Davis, S.2
-
2
-
-
14644406164
-
Diagnosis and management of penicillin allergy
-
Park M, Li TC. Diagnosis and management of penicillin allergy. Mayo Clin Proc 2005;80:405-10.
-
(2005)
Mayo Clin Proc
, vol.80
, pp. 405-410
-
-
Park, M.1
Li, T.C.2
-
4
-
-
0035436901
-
Immunohistology of drug-induced exanthema: Clues to pathogenesis
-
Yawalkar N, Pichler WJ. Immunohistology of drug-induced exanthema: clues to pathogenesis. Curr Opin Allergy Clin Immunol 2001; 1:299-303.
-
(2001)
Curr Opin Allergy Clin Immunol
, vol.1
, pp. 299-303
-
-
Yawalkar, N.1
Pichler, W.J.2
-
6
-
-
13344268993
-
Fas ligand in human serum
-
Tanaka M, Suda T, Haze K et al. Fas ligand in human serum. Nat Med 1996;2:317-22.
-
(1996)
Nat Med
, vol.2
, pp. 317-322
-
-
Tanaka, M.1
Suda, T.2
Haze, K.3
-
7
-
-
0032538505
-
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
-
Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3.
-
(1998)
Science
, vol.282
, pp. 490-493
-
-
Viard, I.1
Wehrli, P.2
Bullani, R.3
-
8
-
-
33947248643
-
Soluble FAS ligand: A discriminating feature between drug-induced skin eruptions and viral exanthemas
-
Stur K, Karlhofer F, Stingl G. Soluble FAS ligand: a discriminating feature between drug-induced skin eruptions and viral exanthemas. J Invest Dermatol 2007;127:802-7.
-
(2007)
J Invest Dermatol
, vol.127
, pp. 802-807
-
-
Stur, K.1
Karlhofer, F.2
Stingl, G.3
-
9
-
-
0037407710
-
Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand
-
Abe R, Shimizu T, Shibaki A et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003;162:1515-20.
-
(2003)
Am J Pathol
, vol.162
, pp. 1515-1520
-
-
Abe, R.1
Shimizu, T.2
Shibaki, A.3
-
12
-
-
0020072598
-
Exfoliative dermatitis during cefoxitin therapy
-
Kannangara DW, Smith B, Cohen K. Exfoliative dermatitis during cefoxitin therapy. Arch Intern Med 1982;142: 1031-2.
-
(1982)
Arch Intern Med
, vol.142
, pp. 1031-1032
-
-
Kannangara, D.W.1
Smith, B.2
Cohen, K.3
-
13
-
-
0025781118
-
Cephalexin induced toxic epidermal necrolysis
-
Dave J, Heathcock R, Fenelon L, Bihari DJ, Simmons NA. Cephalexin induced toxic epidermal necrolysis. J Antimicrob Chemother 1991; 28:477-8.
-
(1991)
J Antimicrob Chemother
, vol.28
, pp. 477-478
-
-
Dave, J.1
Heathcock, R.2
Fenelon, L.3
Bihari, D.J.4
Simmons, N.A.5
-
14
-
-
0016683607
-
Steven-Johnson syndrome with hepatitis following therapy with ampicillin and cephalexin
-
McArthur JE, Dyment PG. Steven-Johnson syndrome with hepatitis following therapy with ampicillin and cephalexin. N Z Med J 1975; 81:390-2.
-
(1975)
N Z Med J
, vol.81
, pp. 390-392
-
-
McArthur, J.E.1
Dyment, P.G.2
-
15
-
-
0036851973
-
Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative β-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability
-
Paquet P, Jacob E, Damas P et al. Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative β-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability. Crit Care Med 2002;30: 2580-3.
-
(2002)
Crit Care Med
, vol.30
, pp. 2580-2583
-
-
Paquet, P.1
Jacob, E.2
Damas, P.3
-
16
-
-
0035856014
-
Cephalosporin allergy
-
Kelkar PS, Li TC. Cephalosporin allergy. N Engl J Med 2001; 345:804-9.
-
(2001)
N Engl J Med
, vol.345
, pp. 804-809
-
-
Kelkar, P.S.1
Li, T.C.2
-
17
-
-
0026693901
-
Allergy to cefazolin: Study of in vivo cross-reactivity with other beta-lactams
-
Igea JM, Fraj J, Davila I et al. Allergy to cefazolin: study of in vivo cross-reactivity with other beta-lactams. Ann Allergy 1992; 68:515-9.
-
(1992)
Ann Allergy
, vol.68
, pp. 515-519
-
-
Igea, J.M.1
Fraj, J.2
Davila, I.3
-
18
-
-
0031006934
-
Cephalosporin allergy: Characterization of unique and cross-reacting cephalosporin antigens
-
Romano A, Quarantino D, Aimone-Gastin I et al. Cephalosporin allergy: characterization of unique and cross-reacting cephalosporin antigens. Int J Immunopathol Pharmacol 1997;10:187-91.
-
(1997)
Int J Immunopathol Pharmacol
, vol.10
, pp. 187-191
-
-
Romano, A.1
Quarantino, D.2
Aimone-Gastin, I.3
-
19
-
-
0034546357
-
Immediate allergic reactions to cephalosporins: Cross-reactivity and selective responses
-
Romano A, Mayorga C, Torres MH et al. Immediate allergic reactions to cephalosporins: Cross-reactivity and selective responses. J Allergy Clin Immunol 2000;106:1177-83.
-
(2000)
J Allergy Clin Immunol
, vol.106
, pp. 1177-1183
-
-
Romano, A.1
Mayorga, C.2
Torres, M.H.3
-
20
-
-
0002334578
-
Drug allergy
-
Patterson R, Grammer LC, Greenberger PA eds, 5th edn. Philadelphia: Lippincott-Raven
-
Deswarte RD, Patterson R. Drug allergy. In: Patterson R, Grammer LC, Greenberger PA (eds). Allergic diseases: diagnosis and management, 5th edn. Philadelphia: Lippincott-Raven, 1997;317-412.
-
(1997)
Allergic diseases: Diagnosis and management
, pp. 317-412
-
-
Deswarte, R.D.1
Patterson, R.2
-
22
-
-
3442876477
-
The lymphocyte transformation test in the diagnosis of drug hypersensitivity
-
Pichler W, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59: 809-20.
-
(2004)
Allergy
, vol.59
, pp. 809-820
-
-
Pichler, W.1
Tilch, J.2
-
23
-
-
0035939368
-
Pyrazinone conjugates as potential cephalosporin allergens
-
Venemalm L. Pyrazinone conjugates as potential cephalosporin allergens. Bioorg Med Chem Lett 2001;11:1869-70.
-
(2001)
Bioorg Med Chem Lett
, vol.11
, pp. 1869-1870
-
-
Venemalm, L.1
-
24
-
-
33749034710
-
Phenotypic diversity in delayed drug hypersensitivity; an immunologic explanation
-
Meth MJ, Sperber KE. Phenotypic diversity in delayed drug hypersensitivity; an immunologic explanation. Mt Sinai J Med 2006;73:769-76.
-
(2006)
Mt Sinai J Med
, vol.73
, pp. 769-776
-
-
Meth, M.J.1
Sperber, K.E.2
|